Redox regulation of caspase-3(-like) protease activity: Regulatory roles of thioredoxin and cytochrome c

Journal of Immunology

Volumn 161, Issue 12, 1998, Pages 6689-6695

  Ueda, Shugo ^a   Nakamura, Hajime ^a   Masutani, Hiroshi ^a   Sasada, Tetsuro ^a   Yonehara, Shin ^a   Takabayashi, Arimichi ^a   Yamaoka, Yoshio ^a   Yodoi, Junji ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYTOCHROME C; PROTEINASE; REACTIVE OXYGEN METABOLITE; THIOREDOXIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; CASPASE 3; CASPASES; CYTOCHROME C GROUP; DIAMIDE; DITHIOTHREITOL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; JURKAT CELLS; MITOCHONDRIA; NECROSIS; NEOPLASM PROTEINS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; THIOREDOXIN;

EID: 0032534748     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Yodoi, J., and T. Uchiyama. 1992. Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation. Immunol. Today 13:405.
2. Nakamura, H., K. Nakamura, and J. Yodoi. 1997. Redox regulation of cellular activation. Annu. Rev. Immunol. 15:351.
3. lck in T cells. Oncogene 8:3133.
4. lck and phosphatidylinositol 3-kinase in T cells by sulfhydryl oxidation: implication of aberrant signaling due to oxidative stress in T lymphocytes. Mol. Immunol. 33: 855.
5. Sato, N., S. Iwaia, K. Nakamura, T. Hori, K. Mori, and J. Yodoi. 1995. Thiol-mediated redox regulation of apoptosis: possible roles of cellular thiols other than glutathione in T cell apoptosis. J. Immunol. 154:3194.
6. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355.
7. Nicholson, D. W., A. Ali, N. A. Thomberry, J. P. Vaillancourt, C. K. Ding, M. Gallant, Y. Gareau, P. R. Griffin, M. Labelle, Y. A. Lazebnik et al. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37.
8. Nicholson, D. W., and N. A. Thornberry. 1997. Caspases: killer proteases. Trends Biochem. Sci. 22:299.
9. Alnemri, E. S., D. J. Livingston, D. W. Nicholson, G. Salvesen, N. A. Thomberry, W. W. Wong, and J. Yuan. 1996. Human ICE/CED-3 protease nomenclature. Cell 87:171.
10. Wilson, K. P., J. A. Black, J. A. Thomson, E. E. Kim, J. P. Griffith, M. A. Navia, M. A. Murcko, S. P. Chambers, R. A. Aldape, S. A. Raybuck, and D. J. Livingston. 1994. Structure and mechanism of interleukin-1β converting enzyme. Nature 370:270.
11. Holmgren, A. 1985. Thioredoxin. Annu. Rev. Biochem. 54:237.
12. Tagaya, Y., Y. Maeda, A. Mitsui, N. Kondo, H. Matsui, J. Hamuro, N. Brown, K. Arai, T. Yokota, H. Wakasugi, and J. Yodoi. 1989. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol reduction in the IL-2 receptor induction. EMBO J. 8:757.
13. Nakamura, H., M. Matsuda, K. Furuke, Y. Kitaoka, S. Iwata, K. Toda, T. Inamoto, Y. Yamaoka, K. Ozawa, and J. Yodoi. 1994. Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol. Lett. 42:75.
14. Sachi, Y., K. Hirota, H. Masutani, K. Toda, T. Okamoto, M. Takigawa, and J. Yodoi. 1995. Induction of ADF/TRX by oxidative stress in keratinocytes and lymphoid cells. Immunol. Lett. 44:189.
15. Sasada, T., S. Iwata, N. Sato, Y. Kitaoka, K. Hirota, K. Nakamura, A. Nishiyama, Y. Taniguchi, A. Takabayashi, and J. Yodoi. 1996. Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity. J. Clin. Invest. 97:2268.
16. Ericson, M. L., J. Horling, H. V. Wendel, A. Holmgren, and A. Rosen. 1992. Secretion of thioredoxin after in vitro activation of human B cells. Lymphokine Cytokine Res. 11:201.
17. Rubartelli, A., A. Bajetto, G. Allavena, E. Wollman, and R. Sitia. 1992. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J. Biol. Chem. 267:24161.
18. Hori, K., M. Katayama, N. Sato, K. Ishii, S. Waga, and J. Yodoi. 1994. Neuroprotection by glial cells through adult T cell leukemia-derived factor/human thioredoxin (ADF/TRX). Brain Res. 652:304.
19. Hirota, K., M. Matsui, S. Iwata, A. Nishiyama, K. Mori, and J. Yodoi. 1997. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. USA 94:3633.
20. Akamatsu, Y., T. Ohno, K. Hirota, H. Kagoshima, J. Yodoi, and K. Shigesada. 1997. Redox regulation of the DNA binding activity in transcription factor PEBP2: the roles of two conserved cysteine residues. J. Biol. Chem. 272:14497.
21. Wakasugi, N., Y. Tagaya, H. Wakasugi. A. Mitsui, M. Maeda, J. Yodoi, and T. Tursz. 1990. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I-and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc. Natl. Acad. Sci. USA 87:8282.
22. Silberstein, D. S., S. McDonough, M. S. Minkoff, and S. M. Balcewicz. 1993. Human eosinophil cytotoxicity-enhancing factor: eosinophil-stimulating and dithiol reductase activities of biosynthetic (recombinant) species with COOH-terminal deletions. J. Biol. Chem. 268:9138.
23. + T cell line-secreted factor, growth promoting for normal and leukemic B cells, identified as thioredoxin. Int. Immunol. 7:625.
24. Matsuda, M., H. Masutani, H. Nakamura, S. Miyajima, A. Yamauchi, S. Yonehara, A. Uchida, K. Irimajiri, A. Horiuchi, and J. Yodoi. 1991. Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. J. Immunol. 147:3837.
25. Mitsui, A., T. Hirakawa, and J. Yodoi. 1992. Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin. Biochem. Biophys. Res. Commun. 186:1220.
26. Yokomise, H., T. Fukuse, T. Hirata, K. Ohkubo, T. Go, K. Muro, K. Yagi, K. Inui, S. Hitomi, A. Mitsui, T. Hirakawa, J. Yodoi, and H. Wada. 1997. Effect of recombinant human adult T cell leukemia-derived factor on rat lung reperfusion injury. Respiration 275:1132.
27. Yonehara, S., A. Ishii, and M. Yonehara, 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-down-regulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747.
28. Hasegawa, J., S. Kamada, W. Kamiike, S. Shimizu, T. Imazu, H. Matsuda, and Y. Tsujimoto. 1996. Involvement of CPP32/Yama(-like) proteases in Fas-mediated apoptosis. Cancer Res. 56:1713.
29. Kobzik, L., J. J. Godleski, and J. D. Brain. 1990. Oxidative metabolism in the alveolar macrophage: analysis by flow cytometry. J. Leukocyte Biol. 47:295.
30. Rothe, G., and G. Valet. 1990. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2′,7′-dichlorofluorescin. J. Leukocyte Biol. 47:440.
31. Liu, X., C. N. Kim, J. Yang, R. Jemmerson, and X. Wang. 1996. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86:147.
32. Deveraux, Q. L., R. Takahashi, G. S. Salvesen, and J. C. Reed. 1997. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388:300.
33. Han, Z., E. A. Hendrickson, T. A. Bremner, and J. H. Wyche. 1997. A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro. J. Biol. Chem. 272:13432.
34. Hampton, M. B., and S. Orrenius. 1997. Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett. 414:552.
35. Hirsch, T., P. Marchetti, S. A. Susin, B. Dallaporta, N. Zamzami, I. Marzo, M. Geuskens, and G. Kroemer. 1997. The apoptosis-necrosis paradox: apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15:1573.
36. Reed, J. C. 1997. Cytochrome c: can't live with it-can't live without it. Cell 91:559.
37. Yang, J., X. Liu, K. Bhalla, C. N. Kim, A. M. Ibrado, J. Cai, T. I. Peng, D. P. Jones, and X. Wang. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129.
38. Kluck, R. M., W. E. Bossy, D. R. Green, and D. D. Newmeyer. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132.
39. Kluck, R. M., S. J. Martin, B. M. Hoffman, J. S. Zhou, D. R. Green, and D. D. Newmeyer. 1997. Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO J. 16:4639.
40. Marchetti, P., D. Decaudin, A. Macho, N. Zamzami, T. Hirsch, S. A. Susin, and G. Kroemer. 1997. Redox regulation of apoptosis: impact of thiol oxidation status on mitochondrial function. Eur. J. Immunol. 27:289.
41. Kroemer, G., N. Zamzami, and S. A. Susin. 1997. Mitochondrial control of apoptosis. Immunol. Today 18:44.
42. Spyrou, G., E. Enmark, V. A. Miranda, and J. A. Gustafsson. 1997. Cloning and expression of a novel mammalian thioredoxin. J. Biol. Chem. 272:2936.
43. Nobel, C. S., D. H. Burgess, B. Zhivotovsky, M. J. Burkitt, S. Orrenius, and A. F. Slater. 1997. Mechanism of dithiocarbamate inhibition of apoptosis: thiol oxidation by dithiocarbamate disulfides directly inhibits processing of the caspase-3 proenzyme. Chem. Res. Toxicol. 10:636.
44. Xia, Z., M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326.
45. Kawasaki, H., T. Morooka, S. Shimohama, J. Kimura, T. Hirano, Y. Gotoh, and E. Nishida. 1997. Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J. Biol. Chem. 272:18518.
46. Saitoh, M., H. Nishitoh, M. Fujii, K. Takeda, K. Tobiume, Y. Sawada, M. Kawabata, K. Miyazono, and H. Ichijo. 1998. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17:2596.
47. Ichijo, H., E. Nishida, K. Irie, D. P. Ten, M. Saitoh, T. Moriguchi, M. Takagi, K. Matsumoto, K. Miyazono, and Y. Gotoh. 1997. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275:90.
48. Sugimoto, C., S. Matsukawa, S. Fujieda, I. Noda, N. Tanaka, H. Tsuzuki, and H. Saito. 1996. Involvement of intracellular glutathione in induction of apoptosis by cisplatin in a human pharyngeal carcinoma cell line. Anticancer Res. 16:675.
49. Chiba, T., S. Takahashi, N. Sato, S. Ishii, and K. Kikuchi. 1996. Fas-mediated apoptosis is modulated by intracellular glutathione in human T cells. Eur. J. Immunol. 26:1164.
50. Delneste, Y., P. Jeannin, E. Sebille, J.-P. Aubry, and J.-Y. Bonnefoy. 1996. Thiols prevent Fas (CD95)-mediated T cell apoptosis by down-regulating membrane Fas expression. Eur. J. Immunol. 26:2981.
51. Furuke, K., and E. T. Bloom. 1998. Redox-sensitive events in Fas-induced apoptosis in human natural killer cells include ceramide generation and protein tyrosine dephosphorylation. Int. Immunol. 10:1261.